Reference
Caroleo B, et al. Glecaprevir/pibrentasvir induced cholestatic jaundice in a HCV patient with renal failure. A case presentation. Current Drug Safety 14: 67-71, No. 1, 2019. Available from: URL: http://doi.org/10.2174/1574886313666181116100452 - Italy
Rights and permissions
About this article
Cite this article
Glecaprevir/pibrentasvir. Reactions Weekly 1747, 137 (2019). https://doi.org/10.1007/s40278-019-59778-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-59778-y